A detailed history of Squarepoint Ops LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 10,333 shares of SAVA stock, worth $34,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,333
Holding current value
$34,615
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.57 - $35.08 $98,886 - $362,481
10,333 New
10,333 $304,000
Q2 2023

Aug 14, 2023

BUY
$21.59 - $27.88 $707,180 - $913,209
32,755 New
32,755 $803,000
Q3 2022

Nov 14, 2022

BUY
$16.33 - $51.06 $342,848 - $1.07 Million
20,995 New
20,995 $878,000
Q2 2022

Aug 15, 2022

SELL
$17.22 - $38.47 $243,473 - $543,927
-14,139 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$32.6 - $53.05 $460,931 - $750,073
14,139 New
14,139 $525,000
Q4 2021

Feb 14, 2022

SELL
$36.77 - $90.91 $1.34 Million - $3.31 Million
-36,405 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$41.79 - $135.3 $1.24 Million - $4.02 Million
29,710 Added 443.76%
36,405 $2.26 Million
Q2 2021

Aug 16, 2021

SELL
$32.15 - $89.72 $1.45 Million - $4.05 Million
-45,090 Reduced 87.07%
6,695 $572,000
Q1 2021

May 17, 2021

SELL
$7.09 - $87.95 $332,946 - $4.13 Million
-46,960 Reduced 47.56%
51,785 $2.33 Million
Q4 2020

Feb 16, 2021

BUY
$6.79 - $12.25 $670,478 - $1.21 Million
98,745 New
98,745 $673,000
Q3 2020

Nov 16, 2020

SELL
$2.86 - $11.51 $53,064 - $213,556
-18,554 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.04 - $9.64 $37,850 - $178,860
18,554 New
18,554 $57,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $134M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.